Ratings
0
Nobody has rated this yet. Be the first!
Works
6
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
